Oncology
ASCO 2023

ASCO 2023 – Gregory Lubiniecki

With its blockbuster checkpoint inhibitor Keytruda, Merck has been a star of the show at many ASCO conferences in recent years.

R&D
Stephen Head, senior director, Patient Partnerships at Astellas Pharma Europe

How can we achieve a world without disease?

Delivering the vision of a world where disease is no longer an insurmountable burden for patients and healthcare professionals would be a phenomenal achievement in the history of medicine.

Sales & Marketing

Digital

Market Access

Market Access
Group of ethnically diverse women

Women's health: Predictions for 2026

A forward glance at new funding vehicles, national strategies, and innovative solutions reshaping the underlying infrastructure of women's care.

Newsletters and Deep Dive
digital magazine

Oncology

Patients

R&D